The developing digital health sector has had to wait almost three years for the public markets to open up to it, but when they did, it was corporate venturing portfolio companies that were first through the flotation exit doors.
And the delay has perhaps been even more surprising with the performance of IRhythm Technologies, a Novo, St Jude and Kaiser Permanente-backed cardiac diagnostics technology developer that floated in October 2016 above its range at $17 per share and has continued to see a steady rise in value to $75 by mid-August this year and a market capitalisation of almost $2bn.
This summer has seen four well-received IPOs of digital healthcare companies, increasing the chances others will follow over the next…
